26 results on '"Colice, Gene"'
Search Results
2. Efficacy Of Tezepelumab In Patients With Severe, Uncontrolled Asthma By Specific Perennial Allergen Immunoglobulin E Thresholds
3. Tezepelumab Efficacy By SNOT-22 Score In Patients With Severe, Uncontrolled Asthma And Comorbid Nasal Polyps In NAVIGATOR
4. Tezepelumab Reduces Exacerbations Across All Seasons In Patients With Severe, Uncontrolled Asthma With Seasonal Allergy: Results From The Phase 3 NAVIGATOR Study
5. Feno differentiates epithelial gene expression clusters: Exploratory analysis from the MESOS randomized controlled trial
6. Tezepelumab Reduces Inflammatory Biomarkers as Early as Week 2 and Maintains Reductions Until Week 52 in the Phase 3 NAVIGATOR Severe Asthma Trial
7. Efficacy of Tezepelumab in Patients with Moderate-to-Severe, Uncontrolled Asthma: A Pooled Analysis of the Phase 2b PATHWAY and Phase 3 NAVIGATOR Studies
8. Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
9. Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with Respiratory Comorbidities: Results from the Phase 3 NAVIGATOR Study
10. Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
11. Tezepelumab Efficacy in Patients with Allergic and Non-Allergic Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study
12. Treatment with Tezepelumab Reduces Serum Interleukin (IL)-5 and IL-13 in Patients with Severe, Uncontrolled Asthma to Levels Approaching those Observed in Healthy Individuals
13. Effect of Tezepelumab on Exacerbations in Patients with Severe, Uncontrolled Asthma, According to Baseline Body Mass Index: Results from the Phase 2b PATHWAY Study
14. Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone
15. Comparative Effectiveness of Extrafine Hydrofluoroalkane Beclometasone (EF HFA-BDP) and Fluticasone Propionate (FP) in Smoking Asthmatic Patients — a Retrospective, Real-Life Observational Study in a UK Primary Care Asthma Population
16. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma
17. Reply
18. Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: A real-world observational study
19. New-onset mild asthma III: A sequel to 2 “Oscar winners”
20. Particle size of inhaled corticosteroids: Does it matter?
21. Oral corticosteroids in poorly controlled asthma
22. Inhaled Corticosteroids
23. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant☆☆☆★
24. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: Assessment with functional helical thin-section computed tomography☆☆☆★
25. Small airway disease: a riddle wrapped in a mystery inside an enigma.
26. Inhaled corticosteroids: past lessons and future issues.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.